Menu

Heterogeneity and prognosis of programmed cell death-ligand 1 expression in the circulating tumor cells of non-small cell lung cancer

He-Lin Wang, Jie-Qing Wu, Ying Wang, Jian Yu, Xiao-Na Mao, Zhuo-Ran Li, Hong-Rui Niu, Cai-Ling Jin, Xiao-Jue Wang, Zhuo-Hong Yan, Ling Yi, Bin Yang, Pan-Jian Wei,  Hong-Tao Zhang,  Shu-Cai Zhang

Abstract:

Due to tumor heterogeneity, the consistency of programmed cell death-ligand 1 (PD-L1) expression between circulating tumor cells (CTCs) and tissue is controversial. This study aimed to establish a method for detecting CTC PD-L1 expression and exploring the impact of the same on the prognosis of lung cancer. In 32 patients with non-small cell lung cancer, lung cancer cells in the blood were enriched using CD326 immunomagnetic beads. Goat anti-mouse polyclonal CD326 antibody stained the epithelial lung cancer cells and anti-PD-L1 antibody was used to detect the expression of CTC PD-L1. The DAKO Link 48 automatic staining device detected the expression in lung cancer tissue. The consistency of PD-L1 expression was analyzed in lung cancer tissue and CTCs. The effect of plasma interferon gamma, tumor necrosis factor alpha, and interleukin-2 on PD-L1 expression and prognosis was analyzed. The number of CTCs detected in patients was 1–36, with a median of 2. There was no significant difference in PD-L1 expression fractions between CTCs and paired tumor tissue (p>0.05). The correlation coefficient was 0.20. Regardless of lung cancer tissue or CTCs, there was no statistically significant difference in the blood cytokine levels between the two groups with positive or negative PD-L1 expression (p>0.05). There was no correlation between CTCs and PD-L1 in 23 untreated patients. The expression of PD-L1 in CTCs and lung cancer tissue is heterogeneous and unaffected by the peripheral cytokines’ levels. PD-L1 expression has no correlation between CTCs and tissues and is not related to prognosis.

Received date: 01/15/2021

Accepted date: 04/08/2021

Ahead of print publish date: 06/07/2021

Issue: 4/2021

Volume: 68

Pages: 823 — 831

Keywords: non-small cell lung cancer, circulating tumor cells, programmed cell death-ligand 1, heterogeneity

DOI: 10.4149/neo_2021_210115N67

Pubmed

Shopping cart is empty